Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder

NCT01564862 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

602

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: vortioxetine (Lu AA21004)
DRUG: Duloxetine
DRUG: Placebo

Sponsor

Takeda